5324

Divi's Laboratories Limited

DIVISLAB.NSE divislabs.com + Research + Basket
ISIN INE361B01024
Employees 11,565
Phone 91 40 6696 6300
Fiscal year end March
Address Divi Towers, Hyderabad, India, 500032
9,780.00
+116.00 (+1.20%)
INR · NSE
52-week range
5,624.31
9,865.00
Trading at 98% of the 52-week range
Market Cap
2.57T
P/E Ratio
87.69
Forward P/E
19.57
Book Value
631.37
Div. Yield
0.00%
% Institutions
29.31%
% Insiders
52.00%

1 Year

+47.6%

3 Year

+192.9%

10 Year

+716.1%
Description

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Actions

Add an action for DIVISLAB.NSE, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm CEO & Whole-Time Director 1976
Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) Executive Director 1958
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. MD & Executive Director 1951
Dr. Devendra Rao Sureddy M.Sc. Whole-Time Director (Manufacturing) 1962
Ms. Nilima Prasad Divi Chief Control Officer, Director of Commercial & Whole-Time Director 1982
Mr. Venkatesa Perumallu Pasumarthy B.Com., F.C.A. Chief Financial Officer 1961
Mr. Manoranjan Jasti Chief Information Officer NA
Mr. Meka Satish Choudhury Company Secretary & Compliance Officer NA
Mr. Satya Prakash Divi B.Tech (Mech), MBA, MS (CIS) Vice President of Sales, Marketing & Logistics 1977
Mr. Y. T. S. Prasad B.E. Global Quality Head 1969

Financial Highlights

▼
Market Cap: $2,565.49B
EBITDA: $39.65B
P/E Ratio: $87.69
Book Value: $631.37
Dividend/Share: $0.00
Dividend Yield: 0.00%
Earnings/Share: $110.21
Profit Margin: 26.05%
Operating Margin: 36.66%
ROA (TTM): 10.07%
ROE (TTM): 16.19%
Revenue (TTM): $112.30B
Revenue/Share (TTM): $423.15
Earnings Growth (YOY): 65.70%
Revenue Growth (YOY): 27.80%

Valuation Metrics

Enterprise Value: $2,505.19B
Trailing P/E: 87.69
Forward P/E: 19.57

Shares Statistics

Shares Outstanding: 265.47M
Shares Float: 117.29M
% Insiders: 52.00%
% Institutions: 29.31%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$105.60B
Cost of Goods Sold
adjust
$-59.98B
Gross Profit
subtotal
$45.62B
SG&A
adjust
$-3.16B
R&D
adjust
$-400.00M
Other Operating Expense
adjust
$-12.28B
Operating Income
subtotal
$29.78B
Other / Non-Operating Items
adjust
$-4.10B
Net Income
subtotal
$25.68B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DIVISLAB.NSE!